Morning Edition
Sat, Mar 21, 2026, 8:58 AM
AI adoption warnings and China's national AI security moves dominate, while brokers push fractional shares and ETF plays. Most chatter is promotional, but regulatory and geopolitical signals cut through.
From Your Network
AI will replace non-AI workers
Reminder that AI-skilled competitors are the real threat to jobs and portfolios.
AI won't replace you, but a person using AI will. Join 500,000+ readers and learn how to use AI in just 5 minutes a day (for free).
China elevates AI safety to national security
Model registration and AGI safety pilots in Beijing could shape global AI regulation.
China classifies AI safety as a national security issue with cybersecurity, biological security & natural disasters. Kwan Yee Ng outlined China’s policies: model registration, safety checks for AI, and AGI safety pilots in Beijing, Shanghai, etc.
FDA skips expert panels for 94% of drugs
Collapse of independent review raises risk for biotech investors and drug safety.
In recent years @US_FDA has systematically avoided expert Advisory Committees for new drug approvals; in 2021, 6% of drug applications were referred to advisory committees, down from 55% in 2010. Should Commissioner @DrMakaryFDA bring back independent Advisory Committees?
Processor alerts expose dispute data
Merchants buying chargeback alerts hand competitive intel to payment giants.
Buying alerts from processors? You're giving them a front-row seat to your dispute data.
IBKR touts 3M global fractional share lead
Widest fractional access lowers entry barriers for retail traders worldwide.
According to Investopedia, Interactive Brokers has more fractional shares available across more markets than anyone else.
New AI & tech ETF ARTY available
Single-ticker exposure to global AI innovators for diversified tech bets.
Invest in global AI & technology innovators with the iShares Future AI & Tech ETF (ARTY).